INTRODUCTION: Given the unknown biologic antecedents before aortic aneurysm rupture, the purpose of this study was to establish a reproducible model of aortic aneurysm rupture. METHODS: We fed 7-week-old apolipoprotein E deficient mice a high-fat diet for 4 weeks and osmotic infusion pumps containing Angiotensin II were implanted. Angiotensin II was delivered continuously for 4 weeks at either 1,000 ng/kg/min (n = 25) or 2,000 ng/kg/min (n = 29). A third group (n = 14) were given Angiotensin II at 2,000 ng/kg/min and 0.2% β-aminopropionitrile dissolved in drinking water. Surviving mice were killed 28 days after pump placement, aortic diameters were measured, and molecular analyses were performed. RESULTS: Survival at 28 days was significantly different among groups with 80% survival in the 1,000 ng/kg/min group, 52% in the 2,000 ng/kg/min group, and only 14% in the Angiotensin II/β-aminopropionitrile group (P = .0001). Concordantly, rupture rates were statistically different among groups (8% versus 38% versus 79%, P < .0001). Rates of abdominal aortic aneurysm were 48%, 55%, and 93%, respectively, with statistically higher rates in the Angiotensin II/β-aminopropionitrile group compared with both the 1,000 ng and 2,000 ng Angiotensin II groups (P = .006 and P = .0165, respectively). Rates of thoracic aortic aneurysm formation were 12%, 52%, and 79% in the 3 groups with a statistically higher rate in the Angiotensin II/β-aminopropionitrile group compared with 1,000 ng group (P < .0001). CONCLUSIONS: A reproducible model of aortic aneurysm rupture was developed with a high incidence of abdominal and thoracic aortic aneurysm. This model should enable further studies investigating the pathogenesis of aortic rupture, as well as allow for targeted strategies to prevent human aortic aneurysm rupture.
INTRODUCTION: Given the unknown biologic antecedents before aortic aneurysm rupture, the purpose of this study was to establish a reproducible model of aortic aneurysm rupture. METHODS: We fed 7-week-old apolipoprotein E deficient mice a high-fat diet for 4 weeks and osmotic infusion pumps containing Angiotensin II were implanted. Angiotensin II was delivered continuously for 4 weeks at either 1,000 ng/kg/min (n = 25) or 2,000 ng/kg/min (n = 29). A third group (n = 14) were given Angiotensin II at 2,000 ng/kg/min and 0.2% β-aminopropionitrile dissolved in drinking water. Surviving mice were killed 28 days after pump placement, aortic diameters were measured, and molecular analyses were performed. RESULTS: Survival at 28 days was significantly different among groups with 80% survival in the 1,000 ng/kg/min group, 52% in the 2,000 ng/kg/min group, and only 14% in the Angiotensin II/β-aminopropionitrile group (P = .0001). Concordantly, rupture rates were statistically different among groups (8% versus 38% versus 79%, P < .0001). Rates of abdominal aortic aneurysm were 48%, 55%, and 93%, respectively, with statistically higher rates in the Angiotensin II/β-aminopropionitrile group compared with both the 1,000 ng and 2,000 ng Angiotensin II groups (P = .006 and P = .0165, respectively). Rates of thoracic aortic aneurysm formation were 12%, 52%, and 79% in the 3 groups with a statistically higher rate in the Angiotensin II/β-aminopropionitrile group compared with 1,000 ng group (P < .0001). CONCLUSIONS: A reproducible model of aortic aneurysm rupture was developed with a high incidence of abdominal and thoracic aortic aneurysm. This model should enable further studies investigating the pathogenesis of aortic rupture, as well as allow for targeted strategies to prevent humanaortic aneurysm rupture.
Authors: William F Johnston; Morgan Salmon; Nicolas H Pope; Akshaya Meher; Gang Su; Matthew L Stone; Guanyi Lu; Gary K Owens; Gilbert R Upchurch; Gorav Ailawadi Journal: Circulation Date: 2014-09-09 Impact factor: 29.690
Authors: Alan Daugherty; Debra L Rateri; Israel F Charo; A Phillip Owens; Deborah A Howatt; Lisa A Cassis Journal: Clin Sci (Lond) Date: 2010-03-09 Impact factor: 6.124
Authors: Anna Z Fashandi; Michael Spinosa; Morgan Salmon; Gang Su; William Montgomery; Alexis Mast; Guanyi Lu; Robert B Hawkins; J Michael Cullen; Ashish K Sharma; Gorav Ailawadi; Gilbert R Upchurch Journal: J Surg Res Date: 2019-11-04 Impact factor: 2.192
Authors: Morgan Salmon; Basil Schaheen; Michael Spinosa; William Montgomery; Nicolas H Pope; John P Davis; William F Johnston; Ashish K Sharma; Gary K Owens; Juanita L Merchant; Zendra E Zehner; Gilbert R Upchurch; Gorav Ailawadi Journal: Arterioscler Thromb Vasc Biol Date: 2019-01 Impact factor: 8.311
Authors: Alexander H Shannon; Craig T Elder; Guanyi Lu; Gang Su; Alexis Mast; Morgan D Salmon; William G Montgomery; Michael D Spinosa; Gilbert R Upchurch; Ashish K Sharma Journal: FASEB J Date: 2020-06-07 Impact factor: 5.191
Authors: Alexander H Shannon; Mahendra D Chordia; Michael D Spinosa; Gang Su; Zachary Ladd; Dongfeng Pan; Gilbert R Upchurch; Ashish K Sharma Journal: J Surg Res Date: 2020-03-12 Impact factor: 2.192
Authors: Alycia G Berman; Daniel J Romary; Katherine E Kerr; Natalyn E Gorazd; Morgan M Wigand; Sourav S Patnaik; Ender A Finol; Abigail D Cox; Craig J Goergen Journal: Sci Rep Date: 2022-01-07 Impact factor: 4.379
Authors: Craig T Elder; Amanda C Filiberto; Gang Su; Zachary Ladd; Victoria Leroy; Eric Y Pruitt; Guanyi Lu; Zhihua Jiang; Ashish K Sharma; Gilbert R Upchurch Journal: FASEB J Date: 2021-08 Impact factor: 5.834